Pennant Group, Inc.
PNTG
DELAYED 1 MONTH
6 insider filings · Latest: May 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | May 27 7:41 PM | Brent GuerisoliChief Executive Officer | Sale | 4,508 | $35.08 | $158.1K | 97,656(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | May 27 7:41 PM | Brent GuerisoliChief Executive Officer | Option Exercise | 8,926 | $3.84 | 0(D) | View → |
| Mar 5, 2026 | Mar 12 7:14 PM | Kirk Sterling CheneyEVP, GC and Corp Secy | Grant/Award | 30,000 | $33.30 | 30,000(D) | View → |
| Mar 5, 2026 | Mar 12 7:14 PM | John J GochnourChief Operating Officer | Grant/Award | 41,000 | $33.30 | 41,000(D) | View → |
| Mar 5, 2026 | Mar 12 7:14 PM | Lynette WalbomChief Financial Officer | Grant/Award | 34,000 | $33.30 | 34,000(D) | View → |
| Mar 5, 2026 | Mar 12 7:14 PM | Jason Paul SteikChief Clinical Officer | Grant/Award | 26,000 | $33.30 | 26,000(D) | View → |
| Mar 5, 2026 | Mar 12 7:14 PM | Brent GuerisoliChief Executive Officer | Grant/Award | 45,000 | $33.30 | 45,000(D) | View → |